Top Ten Pharma Companies of India : January 2021

▴ Top Ten Pharma Companies of India : January 2021
Top ten pharma stocks January 2021

For the year gone by most of the pharma companies have done well and now there will be new contenders in post covid world.Riding on the high demand of Covid drugs ,accessories,vaccines and new approvals from FDA there will be new list soon but before that happens let us look into the pecking order as its is now.

Sun Pharma

Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anti-cancers, steroids, peptides, sex hormones, and controlled substances.The company is headed by Mr Dilip Sanghvi.

Dr Reddy's Lab

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited.Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.Currently Mr Erez Israeli is the CEO.

Cipla

Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.It was founded by Khwaja Abdul Hamied as 'The Chemical, Industrial & Pharmaceutical Laboratories' in 1935 in Mumbai. The name of the Company was changed to 'Cipla Limited' on 20 July 1984.[11] In the year 1985, the US FDA approved the company's bulk drug manufacturing facilities. Led by the founder's son Yusuf Hamied, a Cambridge-educated chemist, the company provided generic AIDS and other drugs to treat poor people in the developing world. In 1995, Cipla launched Deferiprone, the world's first oral iron chelator. In 2001, Cipla offered medicines (antiretrovirals) for HIV treatment at a fractional cost (less than $350 per year per patient). CEO- Mr Umang Vohra

Aurobindo Pharma

Aurobindo Pharma Limited is a pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic/product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. CEO- Mr Arvind Vasudeva


Cadila Health

Cadila Healthcare Limited (also known as Zydus Cadila) is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat, India primarily engaged in the manufacture of generic drugs.Cadila was founded in 1952 by Ramanbhai Patel (1925–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Indravadan Modi. It evolved over the next four decades into an established pharmaceutical company.In 2014, Cadila Healthcare launched the world's first adalimumab biosimilar under the brand name Exemptia at one-fifth the originator's price. Zydus Cadila Healthcare has also launched its first research based drug molecule Saroglitazar in treatment of Diabetic Dyslipidemia under brand name "Lipaglyn". SoviHep is the first sofosbuvir brand launched in India by Zydus in year 2015.Cadila is also developing Covid vaccine and has recieved clearance for the third stage trial of the same.CEO- Mr Pankaj Patel

Divis Labs

Divi's Laboratories Limited is an Indian producer of active pharmaceutical ingredients (APIs) and intermediates headquartered in Hyderabad, Telangana, India. The company manufactures and custom synthesizes generic APIs, intermediates and nutraceutical ingredients.Divi's Laboratories is India's second most valuable pharmaceutical company by market capitalization.Divi's Laboratories was established in 1990 as Divi's Research Centre. The company initially started developing commercial processes for the manufacturing of APIs and intermediates. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry. Following this, the company established its first Manufacturing facility in 1995 at Choutuppal, Telangana. In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam.CEO - Dr Kiran Divi

Glenmark

Glenmark Pharmaceuticals Limited is a pharmaceutical company headquartered in Mumbai, India that was founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer; he named the company after his two sons. The company initially sold its products in India, Russia, and Africa. The company went public in India in 1999, and used some of the proceeds to build its first research facility. Saldanha's son Glenn took over as CEO in 2001, having returned to India after working at PricewaterhouseCoopers. By 2008 Glenmark was the fifth-biggest pharmaceutical company in India.Glenn Saldanha took the company down the path of seeking innovation. The company focused on new drugs and biosimilars in the fields of cancer, dermatology and respiratory diseases, which it sought to monetize by partnering with major pharmaceutical companies. CEO - Glen Mario Saldanha

Alkem Laboratories

Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, India that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India.Alkem set up its research and development facility for ANDA development at Taloja in 2003. In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India. In 2014 Clavam other drug from Alkem crossed 2,000 million mark in terms of domestic sales in India. In 2007 the company filed its first ANDA for drug Amlodipine which was approved in 2009. Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are US FDA, TGA, UK MHRA approved. CEO -Mr Sandeep Singh

Alembic Pharmaceuticals

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara city of Gujarat – India.Alembic Pharmaceuticals Ltd. is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates.Alembic Pharmaceuticals Ltd. initially began as Alembic Chemical Works where it started manufacturing tincture and alcohol at its unit at Vadodara in 1907. The company eventually entered into manufacturing cough syrups, vitamins, tonics and sulphur drug It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.The company has its headquarters and Corporate Office situated in Vadodara, Gujarat – India while its manufacturing facilities are located at Panelav, Karakhadi in Gujarat and Sikkim, India. Its Panelav plant houses active pharmaceutical ingredients (APIs) and formulation manufacturing, while its Sikkim plant is involved in manufacture of formulations for Indian and non-regulated export markets. CEO- Mr Chirayu Amin

Torrent Pharma

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group. Based in the Indian city of Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.Torrent Pharmaceuticals operates in more than 40 countries with over 2000 product registrations globally. Torrent Pharma is active in the therapeutic areas of Cardiovascular (CV), central nervous system (CNS), gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments. Drug firm Torrent Pharmaceuticals on 23 July 2019 reported a 32.51 percent rise in its consolidated net profit to Rs 216 crore for the quarter ended 30 June, mainly on account of robust sales in most geographies. CEO- Mr Chirag Patel

Keep watching this space as we come out with the new top ten list as the new performers  topples the old contenders.

Tags : #TopTenPharmaStocks #TopTenPharmaCompaniesIndia #Cipla #DivisLab #Alkem #Alembic #Glenmark #Torrent #AurodindoPharma #CadilaHealth #ZydusCadila #SunPharma

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Top 4 IVF Centres for High Success RatesJune 24, 2025
Former President Ram Nath Kovind to Inaugurate National Conference of CA Students 2025 in KolkataJune 24, 2025
Bollywood actor Salman Khan says he is suffering from a brain aneurysm, what you need to know about the conditionJune 24, 2025
Butterfly Unveils a Bold New Identity That Celebrates Change and Champions the Original YouJune 24, 2025
8 Daily Habits to Keep Arthritis at BayJune 24, 2025
Food Safety and Drug Administration (FDA), Goa, National Association of Street Vendors of India (NASVI) and Nestlé India expand Project ‘Serve Safe Food’ in GoaJune 24, 2025
Top 4 Startups Driving Credit Risk Innovation in India’s Healthcare and Pharma SectorJune 24, 2025
Sova Health to Host a Free Masterclass on World Microbiome Day, Demystifying Digestive HealthJune 24, 2025
Doctor-Approved Hacks for Better Sleep TonightJune 24, 2025
Indian Assistive Technology Pioneer Prateek Madhav Champions Global Disability Tech Reform with The Royal Society of London Report LaunchJune 24, 2025
Wow! Momo Launches India’s First Gluten-Free Range of Momos – A Game-Changer for Health Conscious FoodiesJune 24, 2025
Medicolegal Risks in TelemedicineJune 24, 2025
Digital Mental Health Clinics in Tier-2 CitiesJune 24, 2025
AssisTech Foundation Hosts Inclusive Job Festival for Persons with DisabilitiesJune 23, 2025
Travel with Ease: Why Congestion Patches Are the Smart Traveler’s Secret WeaponJune 23, 2025
Paper-Tech Platform Paper Arizona Hits ₹100 Cr Annual Revenue Milestone, Eyes IPO Listing in 2026June 23, 2025
Eat Better to enhance its Quick Commerce Operations with UnicommerceJune 23, 2025
Stahl Unveils Blacksmith Signature Cast Iron Tawas: A Classic Essential with a Modern Update for Timeless Indian KitchensJune 23, 2025
Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trialsJune 23, 2025
Finding strength in struggle for gender equality and human rightsJune 23, 2025